SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 237.01 |
Enterprise Value ($M) | 164.44 |
Book Value ($M) | 34.53 |
Book Value / Share | 0.82 |
Price / Book | 6.86 |
NCAV ($M) | -45.07 |
NCAV / Share | -1.07 |
Price / NCAV | -5.26 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.26 |
Return on Assets (ROA) | -0.23 |
Return on Equity (ROE) | -0.61 |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | 11.27 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 167.28 |
Assets | 246.89 |
Liabilities | 212.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -90.14 |
Net Income | -82.37 |
Earnings Per Share Basic And Diluted | -1.03 |
Earnings Per Share Diluted | -1.03 |
Earnings Per Share Basic | -1.03 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -65.51 |
Cash from Investing | -1.76 |
Cash from Financing | -1.76 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Annual Report – 10-K | ||
(click for more detail) |
Similar Companies | |
---|---|
ABCL – AbCellera Biologics Inc. | ABEO – Abeona Therapeutics Inc. |
ABIO – ARCA biopharma, Inc. | ABUS – Arbutus Biopharma Corporation |
ACAD – ACADIA Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io